Porcilis® Porcoli Diluvac Forte
Porcilis Porcoli Diluvac Forte is an inactivated vaccine used to stimulate active immunity of sows/gilts in order to provide passive immunity to their progeny against E. coli strains that express the fimbrial adhesins F4ab, F4ac, F5 and F6.
Presentation
Suspension for injection
Active ingredients
Each dose of 2 ml contains:
Active substances:
Escherichia coli components:
≥9.0 log2 Ab titre1 F4ab (K88ab) fimbrial adhesion
≥5.4 log2 Ab titre1 F4ac (K88ac) fimbrial adhesion
≥6.8 log2 Ab titre1 F5 (K99) fimbrial adhesion
≥7.1 log2 Ab titre1 F6 (987P) fimbrial adhesion
≥6.8 log2 Ab titre1 LT toxoid
The vaccine also contains dl-α-tocopherol acetate as an adjuvant.
1Mean antibody titre (Ab) obtained after vaccination of mice with a 1/20 sow dose.
Target species
Pigs (sows and gilts)
Indications for use
For the passive immunisation of piglets by active immunisation of sows/gilts to reduce mortality and clinical signs such as diarrhoea due to neonatal enterotoxicosis during the first days of life, caused by those E.coli strains, which express the fimbrial adhesins F4ab (K88ab), F4ac (K88ac), F5 (K99) or F6 (987P).
Withdrawal periods
Pigs – meat: 0 days
Packaging
Cardboard box with 1 glass (hydrolytic type I) or 1 PET vial of 20, 50 or 100 ml with a halogenobutyl rubber stopper and a colour-coded aluminium cap. Not all pack sizes may be marketed.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.
Date of preparation: November 2025